Back to results
US 7,452,900 B2Granted
Esters in position 20 of camptothecins
AssigneesSigma-Tau Industrie Farmaceutiche Riunite S.p.A., Istituto Nazionale Per Lo Studio E La Cura Dei Tumori
InventorsMauro Marzi, Domenico Alloatti, Caludio Pisano, Maria Ornella Tinti, Vesci Loredana, Zunino Franco
Life of this patent
Estimating the term…
Abstract
Formula (I) compounds are described: (I) where the groups are as defined in the description here below, the racemic mixtures, their individual enantiomers, their individual diastereoisomers, their mixtures, and their pharmaceutically acceptable salts. Said compounds are topoisomerase I inhibitors.
Claims5
A compound of Formula (I)
- where:
- A is saturated or unsaturated straight or branched C1-C8 alkyl, C3-C10 cycloalkyl, straight or branched C3-C10 cycloalkyl-C1-C8 alkyl;
- n and m are both 0;
- Y is 4-trimethylammonium-3-hydroxybutanoyl, 4-trimethylammonium-butanoyl both in the form of inner salt and in the form of a salt with an anion of a pharmaceutically acceptable acid;
- R1 is hydrogen or a —C(R5)═N—O—R4 group, in which R4 is hydrogen or a straight or branched C1-C5 alkyl or C1-C5 alkenyl group, or a C3-C10 cycloalkyl group, or a straight or branched (C3-C10) cycloalkyl-(C1-C5) alkyl group, or a C6-C14 aryl group, or a straight or branched (C6-C14) aryl-(C1-C5) alkyl group, or a heterocyclic group or a straight or branched heterocyclo-(C1-C5) alkyl group, said heterocyclic group containing at least one heteroatom selected from an atom of nitrogen, optionally substituted with a (C1-C5) alkyl group, and/or an atom of oxygen and/or of sulphur;
- said alkyl, alkenyl, cycloalkyl, cycloalkylalkyl, aryl, aryl-alkyl, heterocyclic or heterocyclo-alkyl groups may optionally be substituted with one or more groups selected from:
- halogen, hydroxy, C1-C5 alkyl, C1-C5 alkoxy, phenyl, cyano, nitro, —NR6R7, where R6 and R7, which may be the same or different, are hydrogen, straight or branched (C1-C5) alkyl, the —COOH group or one of its pharmaceutically acceptable esters;
- or the —CONR8R9 group, where R8 and R9, which may be the same or different, are hydrogen, straight or branched (C1-C5) alkyl;
- or R4 is a (C6-C10) aroyl or (C6-C10) arylsulphonyl residue, optionally substituted with one or more groups selected from:
- halogen, hydroxy, straight or branched C1-C5 alkyl, straight or branched C1-C5 alkoxy, phenyl, cyano, nitro, —NR10R11, where R10 and R11, which may be the same or different, are hydrogen, straight or branched C1-C5 alkyl;
- or R4 is a polyaminoalkyl residue;
- or R4 is a glycosyl residue;
- R5 is hydrogen, straight or branched C1-C5 alkyl, straight or branched C1-C5 alkenyl, C3-C10 cycloalkyl, straight or branched (C3-C10) cycloalkyl-(C1-C5) alkyl, C6-C14 aryl, straight or branched (C6-C14) aryl-(C1-C5) alkyl;
- R2 and R3, which may be the same or different, are hydrogen, hydroxyl, straight or branched C1-C5 alkoxy;
- the N1-oxides, the racemic mixtures, their individual enantiomers, their individual diastereoisomers, their mixtures, and pharmaceutically acceptable salts.
12 more elements
Dependencies are inferred from the claim text.